Treatment of stable chronic moderate to severe heart failure with reduced systolic ventricular function (ejection fraction ≤35%, based on echocardiography) in addition to angiotensin-converting enzyme (ACE) inhibitors and diuretics, and optionally cardiac glycosides.
5 mg FC Tablet: Treatment of hypertension and coronary heart disease (angina pectoris).